Hormonal receptors in endometrial neoplasias

Eur J Gynaecol Oncol. 1988;9(5):396-8.

Abstract

The Authors studied the concentration of cytosolic and nuclear receptor for Estradiol and Progesterone in endometrial hyperplasia and carcinoma, compared with a control group. Comparative study of hormone receptor concentrations in different populations shows: 1) A significant increase in Estradiol receptors in endometrial hyperplasia (p less than 0.01); 2) A decreasing concentration of estradiol receptors with the decreasing of cellular differentiation in endometrial carcinoma (p less than 0.01); 3) A similar tendency and significance for Progesterone receptors; 4) For both receptors the tendency in the nuclear compartment is similar to that in cytosol but the significance is smaller (p less than 0.05).

MeSH terms

  • Endometrial Hyperplasia / drug therapy
  • Endometrial Hyperplasia / metabolism*
  • Endometrial Hyperplasia / pathology
  • Female
  • Humans
  • Medroxyprogesterone / analogs & derivatives
  • Medroxyprogesterone / therapeutic use
  • Medroxyprogesterone Acetate
  • Middle Aged
  • Prospective Studies
  • Receptors, Estradiol / analysis*
  • Receptors, Progesterone / analysis*
  • Tamoxifen / therapeutic use
  • Uterine Neoplasms / analysis*
  • Uterine Neoplasms / drug therapy

Substances

  • Receptors, Estradiol
  • Receptors, Progesterone
  • Tamoxifen
  • Medroxyprogesterone Acetate
  • Medroxyprogesterone